AR082907A1 - Sistemas terapeuticos transdermicos con lamina de proteccion inhibidora de la cristalizacion (release liner) - Google Patents
Sistemas terapeuticos transdermicos con lamina de proteccion inhibidora de la cristalizacion (release liner)Info
- Publication number
- AR082907A1 AR082907A1 ARP110103250A ARP110103250A AR082907A1 AR 082907 A1 AR082907 A1 AR 082907A1 AR P110103250 A ARP110103250 A AR P110103250A AR P110103250 A ARP110103250 A AR P110103250A AR 082907 A1 AR082907 A1 AR 082907A1
- Authority
- AR
- Argentina
- Prior art keywords
- matrix
- transdermal therapeutic
- crystallization
- inhibitant
- release liner
- Prior art date
Links
- 238000002425 crystallisation Methods 0.000 title abstract 2
- 230000008025 crystallization Effects 0.000 title abstract 2
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000011159 matrix material Substances 0.000 abstract 7
- 239000004480 active ingredient Substances 0.000 abstract 3
- 150000002148 esters Chemical class 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 abstract 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000002270 dispersing agent Substances 0.000 abstract 1
- 229960002568 ethinylestradiol Drugs 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 230000001681 protective effect Effects 0.000 abstract 1
- 239000002356 single layer Substances 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102010040299A DE102010040299A1 (de) | 2010-09-06 | 2010-09-06 | Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR082907A1 true AR082907A1 (es) | 2013-01-16 |
Family
ID=44653285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP110103250A AR082907A1 (es) | 2010-09-06 | 2011-09-06 | Sistemas terapeuticos transdermicos con lamina de proteccion inhibidora de la cristalizacion (release liner) |
Country Status (33)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI630208B (zh) | 2008-12-08 | 2018-07-21 | 歐陸斯迪公司 | 二氫羥戊甲嗎啡 |
| GB201309654D0 (en) | 2013-05-30 | 2013-07-17 | Euro Celtique Sa | Method |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH674618A5 (enExample) * | 1987-04-02 | 1990-06-29 | Ciba Geigy Ag | |
| DE58909570D1 (de) | 1988-10-27 | 1996-02-22 | Schering Ag | Mittel zur transdermalen applikation enthaltend gestoden |
| MX9101787A (es) | 1990-10-29 | 1992-06-05 | Alza Corp | Formulaciones,metodos y dispositivos anticonceptivos transdermicos |
| US5512292A (en) | 1990-10-29 | 1996-04-30 | Alza Corporation | Transdermal contraceptive formulations methods and devices |
| DE4210711A1 (de) | 1991-10-31 | 1993-05-06 | Schering Ag Berlin Und Bergkamen, 1000 Berlin, De | Transdermale therapeutische systeme mit kristallisationsinhibitoren |
| DE4336557C2 (de) | 1993-05-06 | 1997-07-17 | Lohmann Therapie Syst Lts | Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
| DE4405899A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Mittel zur transdermalen Applikation enthaltend Desogestrel |
| DE4405898A1 (de) | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
| US5762956A (en) | 1996-04-24 | 1998-06-09 | Rutgers, The State University Of New Jersey | Transdermal contraceptive delivery system and process |
| DE19629468A1 (de) * | 1996-07-11 | 1998-01-15 | Schering Ag | Transdermale therapeutische Systeme |
| DE19827732A1 (de) * | 1998-06-22 | 1999-12-23 | Rottapharm Bv | Transdermales System vom Matrix-Typ zur Abgabe von Wirkstoffen mit einer hohen Abgaberate von Steroid-Hormonen und die Verwendung eines derartigen Systems zur Hormonersatztherapie |
| DE19906152B4 (de) | 1999-02-10 | 2005-02-10 | Jenapharm Gmbh & Co. Kg | Wirkstoffhaltige Laminate für Transdermalsysteme |
| NZ518723A (en) | 1999-11-24 | 2004-04-30 | Agile Therapeutics Inc | Improved transdermal contraceptive delivery system and process |
| DE10053375C1 (de) * | 2000-10-27 | 2002-01-24 | Lohmann Therapie Syst Lts | Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen |
| AU2002235155A1 (en) | 2000-12-05 | 2002-06-18 | Noven Pharmaceuticals, Inc. | Crystallization inhibition of drugs in transdermal drug delivery systems |
| EP1216699A1 (de) | 2000-12-21 | 2002-06-26 | Schering Aktiengesellschaft | Transdermalsystem enthaltend ein hochpotentes Gestagen |
| US20030165547A1 (en) * | 2001-05-18 | 2003-09-04 | Elisabeth Picard-Lesboueyries | Cosmetic uses of 3beta-acetoxy-7-oxo-DHEA |
| DE10261696A1 (de) | 2002-12-30 | 2004-07-15 | Schwarz Pharma Ag | Vorrichtung zur transdermalen Verabreichung von Rotigotin-Base |
| ME00147B (me) * | 2003-02-21 | 2010-10-10 | Schering Ag | Uv-stabilni transdermalni flasteri |
| UA89766C2 (en) * | 2003-12-12 | 2010-03-10 | Байер Шеринг Фарма Акциенгезельшафт | Transdermal delivery system of gestodene |
| US8668925B2 (en) * | 2003-12-12 | 2014-03-11 | Bayer Intellectual Property Gmbh | Transdermal delivery of hormones without the need of penetration enhancers |
| JP4965263B2 (ja) | 2003-12-12 | 2012-07-04 | バイエル ファーマ アクチエンゲゼルシャフト | 浸透増強剤を必要としないホルモンの経皮送達 |
| MX2007004315A (es) * | 2004-10-08 | 2008-03-11 | Noven Pharma | Dispositivo para suministro transdermico de farmaco que incluye un respaldo oclusivo. |
| DE102004062182B4 (de) | 2004-12-20 | 2007-06-06 | Bayer Schering Pharma Ag | Transdermales Pflaster mit Progesteron A-Spezifische Liganden (PRASL) als Wirkstoff |
| US8962013B2 (en) * | 2005-05-02 | 2015-02-24 | Bayer Intellectual Property Gmbh | Multi-layered transdermal system with triazine UV absorber |
| DE102005050729A1 (de) | 2005-10-19 | 2007-04-26 | Schering Ag | Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption |
| AU2009302853B2 (en) * | 2008-10-06 | 2014-09-11 | Mylan Technologies, Inc. | Amorphous rotigotine transdermal system |
-
2010
- 2010-09-06 DE DE102010040299A patent/DE102010040299A1/de not_active Withdrawn
-
2011
- 2011-02-09 UA UAA201304320A patent/UA110217C2/ru unknown
- 2011-09-02 CA CA2810103A patent/CA2810103C/en active Active
- 2011-09-02 SG SG10201506927TA patent/SG10201506927TA/en unknown
- 2011-09-02 NZ NZ607630A patent/NZ607630A/en not_active IP Right Cessation
- 2011-09-02 JP JP2013526490A patent/JP6104800B2/ja not_active Expired - Fee Related
- 2011-09-02 AP AP2013006787A patent/AP3586A/xx active
- 2011-09-02 CU CU20130031A patent/CU24172B1/es active IP Right Grant
- 2011-09-02 MA MA35706A patent/MA34581B1/fr unknown
- 2011-09-02 MY MYPI2013700339A patent/MY162768A/en unknown
- 2011-09-02 BR BR112013005305A patent/BR112013005305A2/pt not_active Application Discontinuation
- 2011-09-02 EP EP11757808.8A patent/EP2613771A1/de not_active Withdrawn
- 2011-09-02 KR KR1020137008726A patent/KR20130114127A/ko not_active Ceased
- 2011-09-02 WO PCT/EP2011/065204 patent/WO2012031985A1/de not_active Ceased
- 2011-09-02 PE PE2013000383A patent/PE20131138A1/es not_active Application Discontinuation
- 2011-09-02 MX MX2013002602A patent/MX2013002602A/es active IP Right Grant
- 2011-09-02 AU AU2011298892A patent/AU2011298892B2/en not_active Ceased
- 2011-09-02 SG SG2013013453A patent/SG187941A1/en unknown
- 2011-09-02 PE PE2017001638A patent/PE20180198A1/es not_active Application Discontinuation
- 2011-09-02 EA EA201390246A patent/EA032575B1/ru not_active IP Right Cessation
- 2011-09-02 CN CN201180042701.6A patent/CN103079549B/zh not_active Expired - Fee Related
- 2011-09-02 PH PH1/2013/500429A patent/PH12013500429A1/en unknown
- 2011-09-05 UY UY0001033590A patent/UY33590A/es unknown
- 2011-09-06 US US13/225,660 patent/US8557279B2/en not_active Expired - Fee Related
- 2011-09-06 AR ARP110103250A patent/AR082907A1/es unknown
- 2011-09-06 TW TW100132149A patent/TWI576245B/zh not_active IP Right Cessation
-
2013
- 2013-02-22 ZA ZA2013/01389A patent/ZA201301389B/en unknown
- 2013-02-28 IL IL224980A patent/IL224980A/en not_active IP Right Cessation
- 2013-03-05 TN TNP2013000087A patent/TN2013000087A1/fr unknown
- 2013-03-06 CO CO13045117A patent/CO6690753A2/es unknown
- 2013-03-06 CR CR20130098A patent/CR20130098A/es unknown
- 2013-03-06 GT GT201300062A patent/GT201300062A/es unknown
- 2013-03-06 CL CL2013000636A patent/CL2013000636A1/es unknown
- 2013-03-06 DO DO2013000053A patent/DOP2013000053A/es unknown
- 2013-03-06 EC ECSP13012477 patent/ECSP13012477A/es unknown
- 2013-09-17 US US14/028,990 patent/US9060955B2/en not_active Expired - Fee Related
-
2016
- 2016-08-22 JP JP2016161929A patent/JP2016216500A/ja active Pending
-
2017
- 2017-03-13 IL IL251124A patent/IL251124B/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2578800T3 (es) | Módulo fotovoltaico que comprende un elemento de conversión espectral localizado y procedimiento de realización | |
| MX2012014060A (es) | Sistema de suministro de ingredientes activos. | |
| CL2011002968A1 (es) | Forma de dosificacion de extrusion por fusion caliente de un ingrediente activo (a) incluido en una matriz que comprende un polimero (c), que el nucleo presenta una orientacion morfologica ortogonal respecto a la direccion longitudinal de extension de la forma de dosificacion; y su procedimiento de preparacion. | |
| AU2011336397A8 (en) | Chemokine CXCR4 receptor modulators and uses related thereto | |
| BR112013030592A2 (pt) | estrutura absorvente para artigos absorventes | |
| AR114086A2 (es) | Polvos para reconstitución | |
| MX2017000429A (es) | Lengüetas de sujecion. | |
| CL2013000735A1 (es) | Uso de una composicion que comprende compuestos derivados de 1-h-imidazol-4-il sustituido para el tratamiento de enfermedades y condiciones de la piel, tales como rosacea, daño solar cronico, psoriasis, entre otras; kit farmaceutico. | |
| PH12015502280A1 (en) | Transdermal delivery system comprising donepezil or its salt | |
| PH12012501523A1 (en) | Dental strip for administration of oral treatment | |
| TW201129470A (en) | Surface protective sheet | |
| AR082907A1 (es) | Sistemas terapeuticos transdermicos con lamina de proteccion inhibidora de la cristalizacion (release liner) | |
| CL2011001829A1 (es) | 3'-n-desmetil-4''-o-(2-dietilaminoetanoil)-6-o-metil-9a-aza-9a-homoeritromicina a, sus sales y formas cristalinas 1, 2 y 3; proceso de preparacion; uso para tratar enfermedades inflamatorias; composicion farmaceutica; y composicion que ademas comprende otro compuesto activo. | |
| BR112015001621A2 (pt) | dispositivo de distribuição | |
| BR112014013878A8 (pt) | emplastro | |
| CL2013000335A1 (es) | Forma altamente cristalina de valsartan; proceso para prepararla; composicion farmaceutica que la comprende y uso en el tratamiento de la hipertension. | |
| AR085060A1 (es) | Composiciones para el tratamiento del cabello con un adhesivo acrilico sensible a la presion | |
| WO2012111996A3 (ko) | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 | |
| CL2009000326A1 (es) | Forma de dosificacion unitaria que comprende una matriz de pelicula delgada que comprende un polimero de matriz soluble en agua y de 10ug a 200 ug de estradiol, o un hidrato o de un ester, con un espesor menor de 300 um, util en una condicion fisica causada por niveles endogenos insuficientes de estrogenos. | |
| JP2013536828A5 (enExample) | ||
| AR082683A1 (es) | Una disposicion de detonacion y un dispositivo para uso en un sistema de detonacion | |
| BR102014025178B8 (pt) | Adesivos à base de acrilatos incorporados com extrato de própolis | |
| AR070617A1 (es) | Formulacion farmaceutica que comprende oxabispidinas/236 | |
| AR130558A2 (es) | Composición farmacéutica que comprende ledipasvir y sofosbuvir, forma de dosificación farmacéutica y comprimido que la comprenden | |
| RU2009131118A (ru) | Наноразмерное анионо-дефектное вещество на основе оксида алюминия для люминесцентного дозиметра ионизирующих излучений |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |